Yayın:
Novel substituted oxadiazole - piperazine derivatives as potential MAO inhibitors: Design, synthesis, in vitro and in silico studies

Sadeleştirilmiş öğe sayfası
dc.contributor.authorOSMANİYE, DERYA
dc.contributor.authorBenkli, Kadriye
dc.contributor.authorDerya Osmani̇ye
dc.contributor.authorKadriye Benkli
dc.contributor.orcid0000-0001-8827-8557
dc.contributor.orcid0000-0002-0151-6266
dc.contributor.orcid0000-0002-0499-436X
dc.contributor.orcid0000-0002-9042-8718
dc.date.accessioned2025-11-13T10:53:09Z
dc.date.issued2021-12-17
dc.identifier.doihttps://doi.org/10.29228/jrp.99
dc.identifier.endpage1044
dc.identifier.issn2630-6344
dc.identifier.issue26(1)
dc.identifier.openalexW4200268217
dc.identifier.startpage1037
dc.identifier.urihttps://hdl.handle.net/11421/5555
dc.identifier.urihttps://doi.org/10.29228/jrp.99
dc.identifier.volume26(1)
dc.language.isoen
dc.relation.ispartofJournal of Research in Pharmacy
dc.rightsopenAccess
dc.subjectPiperazine
dc.subjectIn silico
dc.subjectOxadiazole
dc.subjectIn vitro
dc.subjectChemistry
dc.subjectCombinatorial chemistry
dc.subjectPharmacology
dc.subjectStereochemistry
dc.subjectBiochemistry
dc.subjectBiology
dc.subjectOrganic chemistry
dc.titleNovel substituted oxadiazole - piperazine derivatives as potential MAO inhibitors: Design, synthesis, in vitro and in silico studies
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5017640266
local.authorid.openalexA5040026405

Dosyalar

Koleksiyonlar

Publications